Since being named R&D manager for Boston Scientific Corp. eight years ago, Bob Skribiski has been involved in the development and manufacture of several important medical products, including balloons used in surgery to open arteries. He also has developed sophisticated coextrusion processes, twin-screw compounding processes, injection molding processes, and new compounds and formulations.
He is also part of Boston Scientific's purchasing and supply management initiative, a team that reviews new product specifications before they are sent out for bid, evaluates responses from suppliers, and recommends vendors.
Skribiski has organized two global Boston Scientific technology forums dealing with plastics materials processing and with angioplasty balloons.
Boston Scientific is the largest medical-device company in the world dedicated to minimally-invasive therapy. It employs about 13,500 worldwide.
His other experience includes four years as a materials research engineer with Owens-Illinois' technical center in Toledo, Ohio; three years as a research engineer with Remington Arms Co. Inc in Bridgeport, Conn., where he developed a process for making plastic shotgun shells; and three years as a manufacturing engineer with the Bard-Parker division of Becton-Dickinson in Hancock, N.Y.
Skribiski also spent four years as extrusion manager for the USCI division of C.R. Bard in Billerica, Mass., where he established, staffed and managed the catheter extrusion department and transferred new products from R&D to manufacturing.
During seven years with Electronized Chemicals Co. in Burlington, Mass., he served as R&D engineer, technical service engineer and product manager for a variety of heat-shrinkable tubings and molded shapes for multiple industrial applications.
Previously, Skribiski spent seven years as R&D manager with Baxter-Edwards' LIS Division in Irvine, Calif., where he established and managed a materials research department of 23 people that developed percutaneous transluminal coronary angioplasty balloons, devices used in nonsurgical treatment designed to open blocked arteries, and catheters, and corresponding compounds and formulations.
Boston Scientific's Web site is www.bsci.com.